Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas
Clinical trial NCT01800630 · COMPLETED
Trial details
- NCT number
- NCT01800630
- Sponsor
- InnoPharmax Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2015-11-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.